Skip to main content
Loading
Create Account
Cart
Toggle navigation
Keyword Search
Sign In/Account
Conferences
Toggle
Conference List
Past Meetings
How to Register
Invitation Letter
Submit an Abstract
Poster Display Guidelines
View Abstracts
Cancellations and Transfers
Order an Abstract Booklet
Submit a Conference Concept
Why Participate?
Virtual Keystone Symposia
Financial Aid
Toggle
Student Discounts
Scholarships
Underrepresented Trainee Scholarships
Global Health Travel Awards
Fellows Program
Early-Career Travel Awards
Support Us
Toggle
Donate as a Corporation
Donate as an Individual
Donate as a Foundation
Fund a Fellow
Future of Science Fund
Honor Mentor or Loved One
Current Donors
Gift-in-Kind Media Partners
Contact Development Office
Diversity
Toggle
Career Development Initiatives
Health Disparities Workshops
Fellows Program
Fellows Directory
Underrepresented Trainee Scholarships
Global Health Travel Awards
Early-Career Travel Awards
About
Toggle
Mission and History
Governance
Policies
Contact Us
Join Our Mailing List
Employment Opportunities
Letter From the CEO
Resources
Toggle
Frequently Asked Questions
Attendee Checklist
What to Expect/Bring
Travel Tips and Links
Special Needs
Roommate Bulletin Board
Childcare Bulletin Board
KS Connect App
Loading
This meeting took place in the past. Here is a list of meetings that are related:
Molecular Approaches to Vaccines and Immune Monitoring (2019J5)
Emerging Technologies in Vaccine Discovery and Development (2018J5)
Translational Vaccinology for Global Health (2017S1)
The Modes of Action of Vaccine Adjuvants (2015S1)
Advancing Vaccines in the Genomics Era (2014T1)
Loading
Web Desc
Immunological Mechanisms of Vaccination
Organizer(s): Adrian V.S. Hill, Dan H. Barouch, John T. Harty and Tania H. Watts
Date: December 13 - 18, 2012
Location: Fairmont Château Laurier, Ottawa, ON, Canada
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation
For important information on the coronavirus, please
click here
Summary of Meeting:
Vaccines are remarkably successful in reducing morbidity and mortality from infectious diseases in both developed and developing countries. However, globally, mortality from infectious disease still exceeds 10 million deaths annually, reflecting a need for new, more effective and more deployable vaccination approaches. As many of the relatively easy vaccines have already been made, vaccinology is now tackling more difficult diseases, often caused by complex and genetically variable pathogens. A better understanding of the immunological mechanisms underpinning existing and novel vaccines is therefore required. Fortunately, research efforts to uncover new molecular and cellular techniques offer exceptional opportunities for improved vaccine design. A better understanding of the immunology of vaccination will be of value in evidence-based design of new vaccines against major global causes of mortality such as HIV, malaria and tuberculosis, and against emerging infections such as swine influenza and dengue. Advances in immunology, genomics and systems biology are beginning to offer a deeper understanding of the molecular and cellular mechanisms of host immunity, and the pivotal role played by the innate immune system in shaping the adaptive immune response. This is providing new opportunities to identify new signatures of vaccine immunogenicity and protective efficacy, which should facilitate vaccine development and guide improved vaccine design. The Keystone Symposia meeting on Immunological Mechanisms of Vaccination will bring together an interdisciplinary group of scientists in vaccinology, immunology and pathogen biology, to address recent advances in these fields and their potential for accelerating vaccine design and development.
Global Health Travel Award Deadline: July 18 2012
Scholarship Deadline: August 13 2012
Discounted Abstract Deadline: August 13 2012
Abstract Deadline: September 13 2012
Discounted Registration Deadline: October 11 2012
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Novartis Vaccines and Diagnostics
We gratefully acknowledge the generous grant for this conference provided by:
National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI102519-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
Program
Loading
Thursday, December 13
| 12:00PM - 7:30PM
Arrival and Registration
Room: Main Lobby
Thursday, December 13
| 4:00PM - 5:30PM
Welcome and Keynote Address (Joint with Grand Challenges Mee
ting)
Room: Canada Hall 1, Ottawa Convention Centre
Speaker 1 of 3
* Christopher L. Karp
, Bill & Melinda Gates Foundation, USA
Thursday, December 13
| 4:00PM - 5:30PM
Welcome and Keynote Address (Joint with Grand Challenges Mee
ting)
Room: Canada Hall 1, Ottawa Convention Centre
Speaker 2 of 3
Chris Wilson
, Bill & Melinda Gates Foundation, USA
Translating Immunology into Vaccinology
Thursday, December 13
| 4:00PM - 5:30PM
Welcome and Keynote Address (Joint with Grand Challenges Mee
ting)
Room: Canada Hall 1, Ottawa Convention Centre
Speaker 3 of 3
Bruce A. Beutler
, University of Texas Southwestern Medical Center, USA
Genetics and Innate Immunity
Thursday, December 13
| 5:30PM - 8:00PM
Social Hour with Lite Bites
Room: Trillium Ballroom, Ottawa Convention Centre
Friday, December 14
| 7:30AM - 9:00AM
Breakfast
Room: Adam/Drawing Rooms
Friday, December 14
| 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom
Speaker 1 of 7
* Julie Magarian Blander
, Weill Cornell Medicine, Cornell University, USA
Friday, December 14
| 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom
Speaker 2 of 7
Stephanie C. Eisenbarth
, Yale University, USA
NLR Regulation of Dendritic Cell Priming during Immunization
Friday, December 14
| 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom
Speaker 3 of 7
Yan Shi
, University of Calgary, Canada
Immune Activation by Force
Friday, December 14
| 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom
Speaker 4 of 7
Dana Philpott
, University of Toronto, Canada
Nod Proteins: Regulators of Inflammation and Autophagy
Friday, December 14
| 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom
Speaker 5 of 7
William R. Heath
, University of Melbourne, Australia
Dendritic Cell Receptors and T Cell Induction
Friday, December 14
| 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom
Speaker 6 of 7
Nicolas Chevrier
, Harvard University, USA
Short Talk: System-Level Analysis of the Toll-Like Receptor Network Delineates Viral and Inflammatory Sensing Circuits
Friday, December 14
| 9:00AM - 12:15PM
Innate Sensing of Pathogens and Vaccines
Room: Ballroom
Speaker 7 of 7
Taryn L. Osmond
, Malaghan Institute of Medical Research, New Zealand
Short Talk: Splenic CD8alpha+Langerin+ Dendritic Cells: Firing up the Immune Environment for CD8+ T Cell Responses
Friday, December 14
| 10:20AM - 10:40AM
Coffee Break
Room: Adam/Drawing Rooms
Friday, December 14
| 12:15PM - 1:00PM
Poster Setup
Room: Adam/Drawing Rooms
Friday, December 14
| 12:15PM - 12:15PM
On Own for Lunch and Recreation
Friday, December 14
| 1:00PM - 10:00PM
Poster Viewing
Room: Adam/Drawing Rooms
Friday, December 14
| 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom
Speaker 1 of 9
* Katrina D. Gee
, Queen's University, Canada
Friday, December 14
| 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom
Speaker 2 of 9
* Sam Basta
, Queen's University, Canada
Friday, December 14
| 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom
Speaker 3 of 9
Frank Wegmann
, Janssen, Netherlands
Polyethyleneimine is a Potent Mucosal Adjuvant for Glycoproteins with Innate and Adaptive Immune Activating Properties
Friday, December 14
| 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom
Speaker 4 of 9
Sang Mu Shim
, Korea Research Institute of Bioscience and Biotechnology (KRIBB), South Korea
Poly gamma Glutamic Acid-Chitosan Nanogel Dramatically Enhance the Efficacy of Pandemic H1N1 Influenza Vaccine
Friday, December 14
| 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom
Speaker 5 of 9
Thomas W. Dubensky, Jr.
, Tempest Therapeutics, USA
Development of Cyclic Dinucleotides (CDNs) as STING-Targeted Molecular Adjuvants
Friday, December 14
| 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom
Speaker 6 of 9
Karen Smith Korsholm
, Statens Serum Institut, Denmark
The Effect of the Immunostimulating Glycolipid MMG in Cationic Liposomal Vaccine Adjuvants
Friday, December 14
| 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom
Speaker 7 of 9
Silvia Vendetti
, Istituto Superiore di Sanità, Italy
Achieving Mucosal and Systemic Immunity by Exploiting Vitamin A Metabolites as Vaccine Co-Adjuvants
Friday, December 14
| 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom
Speaker 8 of 9
Esteban Celis
, Moffitt Cancer Center, USA
BiVax: A Peptide/Poly-IC Subunit Vaccine that Mimics an Acute Infection Elicits Vast and Effective Anti-Tumor CD8 T Cell Responses
Friday, December 14
| 2:00PM - 4:00PM
Workshop 1: Novel Adjuvants
Room: Ballroom
Speaker 9 of 9
Maria L. Knudsen
, Fred Hutchinson Cancer Research Center, USA
Alphavirus Replicons Encoding the TLR5 Ligand Flagellin is a Potent Adjuvant for IgG Response
Friday, December 14
| 4:00PM - 4:30PM
Coffee Available
Room: Adam/Drawing Rooms
Friday, December 14
| 4:30PM - 7:15PM
Augmenting Immune Responses to Vaccines
Room: Ballroom
Speaker 1 of 6
* Dan H. Barouch
, Beth Israel Deaconess Medical Center, USA
Friday, December 14
| 4:30PM - 7:15PM
Augmenting Immune Responses to Vaccines
Room: Ballroom
Speaker 2 of 6
Robert A. Seder
, NIAID, National Institutes of Health, USA
Differential Effects of Innate Immunity and Antigen Load on CD8 T Cell Immunity Following Viral Vaccination
Friday, December 14
| 4:30PM - 7:15PM
Augmenting Immune Responses to Vaccines
Room: Ballroom
Speaker 3 of 6
Tania H. Watts
, University of Toronto, Canada
CD137L (4-1BBL) as an Immune Stimulant in Acute and Chronic Viral Infections
Friday, December 14
| 4:30PM - 7:15PM
Augmenting Immune Responses to Vaccines
Room: Ballroom
Speaker 4 of 6
Rafick Sekaly
, Case Western Reserve University, USA
Systems Biology Approaches Show the Impact of Ethnic Groups on Innate and Adaptive Characteristics that Correlate with Protective Immune Responses to the Yellow Fever Vaccine
Friday, December 14
| 4:30PM - 7:15PM
Augmenting Immune Responses to Vaccines
Room: Ballroom
Speaker 5 of 6
Daniel D. Pinschewer
, University of Geneva, Switzerland
LCMV-Based Vaccine Vectors: Viral Immunobiology Teaches Vaccinology
Friday, December 14
| 4:30PM - 7:15PM
Augmenting Immune Responses to Vaccines
Room: Ballroom
Speaker 6 of 6
Nicolas Cuburu
, NIH, National Cancer Institute, USA
Short Talk: Prime/Boost Genital Immunization with Human Papillomaviral Vectors Preferentially Induces CD103+CD8+ Tissue Resident Memory Cells in the Mouse Female Genital Tract
Friday, December 14
| 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Adam/Drawing Rooms
Friday, December 14
| 7:30PM - 10:00PM
Poster Session 1
Room: Adam/Drawing Rooms
Saturday, December 15
| 7:30AM - 9:00AM
Breakfast
Room: Adam/Drawing Rooms
Saturday, December 15
| 8:00AM - 9:00AM
Poster Setup
Room: Adam/Drawing Rooms
Saturday, December 15
| 9:00AM - 5:00PM
Poster Viewing
Room: Adam/Drawing Rooms
Saturday, December 15
| 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom
Speaker 1 of 8
* Nathalie Labrecque
, Maisonneuve-Rosemont Hospital Research Centre, Canada
Saturday, December 15
| 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom
Speaker 2 of 8
* Susan M. Kaech
, The Salk Institute, USA
Saturday, December 15
| 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom
Speaker 3 of 8
Ton N. Schumacher
, Netherlands Cancer Institute, Netherlands
Technologies for Tracking T Cell Responses
Saturday, December 15
| 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom
Speaker 4 of 8
John T. Harty
, University of Iowa, USA
Alternative Strategies for Generating Protective Numbers of Memory CD8 T Cells by Prime-Boost Immunization
Saturday, December 15
| 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom
Speaker 5 of 8
Ross M. Kedl
, University of Colorado Denver, USA
Short Talk: Antigen Persistence after Subunit Vaccination Correlates with the Generation and Maintenance of Protective Cellular Immunity
Saturday, December 15
| 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom
Speaker 6 of 8
Marc K. Jenkins
, University of Minnesota Medical School, USA
Origins of CD4+ Memory T Cells
Saturday, December 15
| 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom
Speaker 7 of 8
David B. Masopust
, University of Minnesota, USA
CD8 T Cell Memory Induced by Heterologous Prime-Boost Vaccination
Saturday, December 15
| 9:00AM - 12:15PM
T Cell Memory to Vaccines
Room: Ballroom
Speaker 8 of 8
Cara Skon
, Genentech, Inc., USA
Short Talk: Transcriptional Downregulation of S1PR1 is Required for Establishment of Resident Memory CD8 T Cells
Saturday, December 15
| 10:20AM - 10:40AM
Coffee Break
Room: Adam/Drawing Rooms
Saturday, December 15
| 12:15PM - 1:15PM
Lunch
Room: Adam/Drawing Rooms
Saturday, December 15
| 1:00PM - 3:30PM
Poster Session 2
Room: Adam/Drawing Rooms
Saturday, December 15
| 3:30PM - 4:00PM
Coffee Available
Room: Adam/Drawing Rooms
Saturday, December 15
| 4:00PM - 6:00PM
B Cell Memory to Vaccines
Room: Ballroom
Speaker 1 of 6
* Jamie K. Scott
, Simon Fraser University, Canada
Saturday, December 15
| 4:00PM - 6:00PM
B Cell Memory to Vaccines
Room: Ballroom
Speaker 2 of 6
* Richard A. Kroczek
, Robert Koch-Institute, Germany
Saturday, December 15
| 4:00PM - 6:00PM
B Cell Memory to Vaccines
Room: Ballroom
Speaker 3 of 6
Bonnie B. Blomberg
, University of Miami School of Medicine, USA
Biomaker and Molecular Mechanisms for Human B cell and Antibody Responsiveness to Vaccines
Saturday, December 15
| 4:00PM - 6:00PM
B Cell Memory to Vaccines
Room: Ballroom
Speaker 4 of 6
Michel C. Nussenzweig
, HHMI/Rockefeller University, USA
Human Antibody Responses to HIV
Saturday, December 15
| 4:00PM - 6:00PM
B Cell Memory to Vaccines
Room: Ballroom
Speaker 5 of 6
Shane Crotty
, La Jolla Institute for Immunology, USA
Tfh Cells: Providing T Cell Help for B Cell Responses
Saturday, December 15
| 4:00PM - 6:00PM
B Cell Memory to Vaccines
Room: Ballroom
Speaker 6 of 6
Peter Sage
, Harvard Medical School, USA
Short Talk: PD-1 Controls Lymph Node and Blood T Follicular Regulatory Cells
Saturday, December 15
| 5:00PM - 5:00PM
On Own for Dinner
Sunday, December 16
| 7:30AM - 9:00AM
Breakfast
Room: Adam/Drawing Rooms
Sunday, December 16
| 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom
Speaker 1 of 7
* Bonnie B. Blomberg
, University of Miami School of Medicine, USA
Sunday, December 16
| 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom
Speaker 2 of 7
* Vladimir Badovinac
, University of Iowa, USA
Sunday, December 16
| 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom
Speaker 3 of 7
Bali Pulendran
, Stanford University School of Medicine, USA
Systems Vaccinology: Enabling Rational Vaccine Design with Systems Biology
Sunday, December 16
| 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom
Speaker 4 of 7
Ennio De Gregorio
, GlaxoSmithKline Vaccines, Italy
Immune Profiling of Vaccine Adjuvants
Sunday, December 16
| 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom
Speaker 5 of 7
Susan M. Kaech
, The Salk Institute, USA
Regulation or Antiviral Immunity by PGE-2 During Chronic Viral Infection
Sunday, December 16
| 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom
Speaker 6 of 7
Willem A. Hanekom
, Bill & Melinda Gates Foundation, USA
Human Gene Expression Signatures of Risk of Tuberculosis Disease
Sunday, December 16
| 9:00AM - 11:45AM
Understanding Signatures of Vaccine Protective Efficacy
Room: Ballroom
Speaker 7 of 7
Magali Matsumiya
, University of Oxford, UK
Short Talk: Predicting the Immune Response to MVA85A
Sunday, December 16
| 10:20AM - 10:40AM
Coffee Break
Room: Adam/Drawing Rooms
Sunday, December 16
| 11:45AM - 1:00PM
Poster Setup
Room: Adam/Drawing Rooms
Sunday, December 16
| 11:45AM - 11:45AM
On Own for Lunch and Recreation
Sunday, December 16
| 1:00PM - 10:00PM
Poster Viewing
Room: Adam/Drawing Rooms
Sunday, December 16
| 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom
Speaker 1 of 9
* Adrian V. S. Hill
, Jenner Institute, University of Oxford, UK
Sunday, December 16
| 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom
Speaker 2 of 9
Peter Lauer
, Aduro BioTech, Inc., USA
Recombinase-Induced Intracellular Death (Lm-RIID): A Novel, Safe, and Potent L. Monocytogenes Vaccine Platform
Sunday, December 16
| 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom
Speaker 3 of 9
Ana Carolina dos Reis Albuquerque Cajaraville
, Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos, Brazil
Characterization of a Malaria Vaccine Candidate Based in the Yellow Fever 17D Virus Vector
Sunday, December 16
| 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom
Speaker 4 of 9
Matthew D. J. Dicks
, University of Oxford, UK
Why Are Some Adenovirus Vaccine Vectors More Immunogenic Than Others?
Sunday, December 16
| 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom
Speaker 5 of 9
* Allan Randrup Thomsen
, University of Copenhagen, Denmark
Generation of Transgene-Specific CD8 T Cells by Immunization with Adenoviral Vectors Is Markedly Augmented by Co-Expression of Transgene and IL-2 in the Same Vector
Sunday, December 16
| 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom
Speaker 6 of 9
Torben Knuschke
, University of Duisburg-Essen, Germany
Biodegradable Calcium Phosphate Nanoparticles: A New Conjugated Vaccine Approach for Prophylactic and Therapeutic Anti-Viral Treatment
Sunday, December 16
| 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom
Speaker 7 of 9
Masaru Kanekiyo
, NIAID, National Institutes of Health, USA
A Self-Assembling Influenza Nanoparticle Vaccine Elicits Broad and Potent Neutralizing Antibodies
Sunday, December 16
| 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom
Speaker 8 of 9
Even Fossum
, Institute of Immunology, Norway
Vaccines Designed to Specifically Target Cross-Presenting DCs
Sunday, December 16
| 2:30PM - 4:30PM
Workshop 2: Vaccine Delivery
Room: Ballroom
Speaker 9 of 9
Shaomin Tian
, University of North Carolina at Chapel Hill, USA
Rational Design of PRINT Nano-Vaccines
Sunday, December 16
| 4:30PM - 5:00PM
Coffee Available
Room: Adam/Drawing Rooms
Sunday, December 16
| 5:00PM - 7:00PM
Translating Immunity to Vaccines
Room: Ballroom
Speaker 1 of 6
* Tania H. Watts
, University of Toronto, Canada
Sunday, December 16
| 5:00PM - 7:00PM
Translating Immunity to Vaccines
Room: Ballroom
Speaker 2 of 6
Dan H. Barouch
, Beth Israel Deaconess Medical Center, USA
Novel HIV Vaccine Strategies
Sunday, December 16
| 5:00PM - 7:00PM
Translating Immunity to Vaccines
Room: Ballroom
Speaker 3 of 6
Helen McShane
, Jenner Institute, UK
Clinical Development of TB Vaccines
Sunday, December 16
| 5:00PM - 7:00PM
Translating Immunity to Vaccines
Room: Ballroom
Speaker 4 of 6
Daniela Weiskopf
, La Jolla Institute for Immunology, USA
Short Talk: Comprehensive Analysis of Dengue Virus-Specific Responses Supports an HLA-Linked Protective Role for CD8+ T Cells, Rather Than a Pathogenic Role Linked to Original Antigenic Sin
Sunday, December 16
| 5:00PM - 7:00PM
Translating Immunity to Vaccines
Room: Ballroom
Speaker 5 of 6
Ma Luo
, University of Manitoba, Canada
Short Talk: Antibody and T Cell Response to the Protease Cleavage Sites Correlated with Protection Against Higher Dose of SIVmac239 Challenge and Disease Progression in Cynomolgus Macaques
Sunday, December 16
| 5:00PM - 7:00PM
Translating Immunity to Vaccines
Room: Ballroom
Speaker 6 of 6
Bram Slütter
, University of Iowa, USA
Short Talk: CXCR3+ Memory CD8+ T Cells Localize to the Respiratory Tract and Provide Superior Protection Against Influenza A Virus
Sunday, December 16
| 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Adam/Drawing Rooms
Sunday, December 16
| 7:30PM - 10:00PM
Poster Session 3
Room: Adam/Drawing Rooms
Monday, December 17
| 7:30AM - 9:00AM
Breakfast
Room: Adam/Drawing Rooms
Monday, December 17
| 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom
Speaker 1 of 8
* John T. Harty
, University of Iowa, USA
Monday, December 17
| 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom
Speaker 2 of 8
* Helen McShane
, Jenner Institute, UK
Monday, December 17
| 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom
Speaker 3 of 8
Adrian V. S. Hill
, Jenner Institute, University of Oxford, UK
Generating Unnatural Immunity
Monday, December 17
| 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom
Speaker 4 of 8
Rafi Ahmed
, Emory University School of Medicine, USA
Human B Cell Response to Influenza Virus
Monday, December 17
| 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom
Speaker 5 of 8
Dennis L. Kasper
, Harvard Medical School, USA
Rethinking Glycocojugate Vaccines: A Knowledge-Based Approach to Vaccine Design
Monday, December 17
| 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom
Speaker 6 of 8
Claire A. Jones
, University of Oxford, UK
Short Talk: Quantification of Antibody Secreting Cell Responses in a Human Model of Salmonella typhi Infection
Monday, December 17
| 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom
Speaker 7 of 8
Mark Y. Sangster
, University of Rochester, USA
Short Talk: The B Cell Response to an Inactivated Pandemic H1N1 Influenza Vaccine in Cohorts Differing by Age and Immune Status
Monday, December 17
| 9:00AM - 12:15PM
Immunity and Vaccines Against Global Threats I
Room: Ballroom
Speaker 8 of 8
David Furman
, Buck Institute for Research on Aging, USA
Short Talk: Robust Correlates of an Immune Response to Influenza Vaccination in Young and Old Adults
Monday, December 17
| 10:20AM - 10:40AM
Coffee Break
Room: Adam/Drawing Rooms
Monday, December 17
| 12:15PM - 12:15PM
On Own for Lunch and Recreation
Monday, December 17
| 4:30PM - 5:00PM
Coffee Available
Room: Adam/Drawing Rooms
Monday, December 17
| 5:00PM - 7:00PM
Immunity and Vaccines Against Global Threats II
Room: Ballroom
Speaker 1 of 6
* Adrian V. S. Hill
, Jenner Institute, University of Oxford, UK
Monday, December 17
| 5:00PM - 7:00PM
Immunity and Vaccines Against Global Threats II
Room: Ballroom
Speaker 2 of 6
* Alessandro Sette
, La Jolla Institute for Immunology, USA
Monday, December 17
| 5:00PM - 7:00PM
Immunity and Vaccines Against Global Threats II
Room: Ballroom
Speaker 3 of 6
Dany De Grave
, Sanofi Pasteur, USA
The Sanofi Pasteur Tetravalent Dengue Vaccine: An Update
Monday, December 17
| 5:00PM - 7:00PM
Immunity and Vaccines Against Global Threats II
Room: Ballroom
Speaker 4 of 6
Louis J. Picker
, Oregon Health & Science University, USA
Unique Immunobiology and Efficacy of SIV Protein-Expressing Cytomegalovirus (CMV) Vectors
Monday, December 17
| 5:00PM - 7:00PM
Immunity and Vaccines Against Global Threats II
Room: Ballroom
Speaker 5 of 6
Jerald C. Sadoff
, Crucell Vaccine Institute, Janssen Pharmaceutical Companies of Johnson & Johnson, Netherlands
Vaccine Vectors for HIV and Other Global Threats
Monday, December 17
| 5:00PM - 7:00PM
Immunity and Vaccines Against Global Threats II
Room: Ballroom
Speaker 6 of 6
David M. Lewinsohn
, Oregon Health & Science University, USA
Short Talk: Lessons from a Human Phase I Trial: Vaccination with the Mtb Vaccine AERAS-402 (BCG Prime / Adenoviral Boost) Induces High Frequency, Antigen-Specific CD8 T Cells That Do Not Necessarily Recognize the Mtb-Infected Cell
Monday, December 17
| 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Adam/Drawing Rooms
Monday, December 17
| 8:00PM - 11:00PM
Entertainment
Room: Adam Room
Monday, December 17
| 8:00PM - 11:00PM
Cash Bar
Room: Adam Room
Tuesday, December 18
| 10:23AM - 10:23AM
Departure
*Session Chair
†Invited, not yet responded.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##